Home / Knowledge Centre /
Case study

Flexible IXRS® design supports multiple extension studies

Self-service speeds amendments, saving thousands

In software design, there is typically a trade-off between automation and flexibility; the more automated an Interactive Response Technology (IRT) is in controlling visit schedules, drug assignments and inventory, the less flexibility there is to accommodate new protocols and patient cohorts without incurring additional costs.

This business case describes how Almac Clinical Technologies’ unique solution allows for optimal flexibility without compromising study efficiency – even for trials with umbrella designs and multiple extension studies arising from a number of parent studies. The resulting cost savings are directly attributable to the following:

  • Reducing the number of IRT systems needed
  • Providing a self-service visit schedule design that meets the site need for flexibility and still allows for accurate drug projections
  • Implementing effective drug management/drug pooling strategies
View Resource
Almac Logo

Almac Clinical Technologies

Almac Clinical Technologies is here to help the biopharmaceutical industry bring new therapies to those in need by empowering clinical trial sponsors to proactively manage sites, patients, and clinical trial supplies through our industry-leading Interactive Response Technology (IRT) and expert consultancy.

Almac Clinical Technologies is uniquely positioned to unlock new efficiencies in the clinical supply chain and to help achieve greater predictability in your projects and programs.

Our professionals are dedicated to delivering high-quality Interactive Response Technology (IRT) solutions, dependable professional services, and reliable customer service. Our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies